Phase 1 B-cell Non-Hodgkin Lymphomas Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas

Antengene Biologics Limited80 enrolled4 locationsNCT06028373

Completed

Phase 1

A Phase I, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of single oral dose of HMPL-689 in Healthy Adult Participants

B-cell Non-Hodgkin Lymphomas

INC Research Australia Pty Ltd56 enrolled1 locationACTRN12616000451404